Clinical Trial Update: Efficacy of Pediococcus Acidilactici as add-on to Antipsychotic Drugs on Metabolic Syndrome Disturbances in First-episode Psychosis and Schizophrenia Spectrum Disorders. [NA]

View source ↗

Summary

A completed clinical trial evaluated whether adding Pediococcus acidilactici to antipsychotic therapy improves metabolic syndrome disturbances in individuals wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• First Episode Psychosis
• Metabolic Syndrome
• Schizophrenia

Drugs mentioned

• Pediococcus acidilactici (Pediococcus acidilactici)

Snippet

Sponsor: Manuel Jesús Cuesta Zurita | Conditions: SCHIZOPHRENIA 1 (Disorder), Metabolic Abnormalities | NA | Status: COMPLETED